Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.32 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | CSF1R | P07333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4903657 | 0.78 | SLC29A1 (0.38) | KDM4EALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL4894592 | 0.78 | MEN1 (0.36) | KDM4EALDH1A1MEN1KMT2ATP53 | |
| SCHEMBL4897940 | 0.78 | DUT (0.34) | MEN1KMT2ASLC29A1 | |
| SCHEMBL24999134 | 0.73 | ADORA2A (0.45) | KDM4EUSP2ALDH1A1LMNATSHR | |
| SCHEMBL6177913 | 0.72 | MEN1 (0.40) | KDM4EALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1106478 | 0.70 | PDE4A (0.43) | KDM4EALDH1A1MEN1KMT2ATP53 | |
| SCHEMBL15157587 | 0.65 | POLB (0.41) | KDM4EALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL15157890 | 0.64 | POLB (0.42) | KDM4EALDH1A1LMNATSHRMEN1 | |
| SCHEMBL24668965 | 0.64 | HTT (0.40) | ALOX15TSHRMEN1KMT2ATP53 | |
| SCHEMBL4865265 | 0.64 | MEN1 (0.37) | KDM4EALDH1A1MEN1KMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080318878-A1 | Antibacterial Agents | RANBAXY LABORATRIES LIMITED (IN) | 2008-12-25 | — | — | US | disclosed |
| EP-1812455-A2 | ERYTHROMYCIN A DERIVATIVES AS ANTIBACTERIAL AGENTS | Ranbaxy Laboratories Limited (IN) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006035301-A2 | ERYTHROMYCIN A DERIVATIVES AS ANTIBACTERIAL AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2006-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318878-A1 | Antibacterial Agents | MLX, MGAM, CAT | KDM4E 3935/4885USP2 3374/4885ALDH1A1 3139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.